Latest News
Futures Edge Higher Ahead of Delayed Jobs Data; AI Tax Tool Hits Brokerages
U.S. stock futures rose slightly as markets awaited a postponed January employment report. Brokerage stocks slumped on concerns about AI-driven disruption.
RELX Shares Approach Annual Low Amid AI Concerns Ahead of Earnings
RELX shares fell nearly 3% in early London trading, nearing a 52-week low as investors await annual results. The decline reflects broader anxiety over AI's impact on data and analytics firms.
LSEG Shares Surge as Elliott Management Takes Activist Position, Advocates for Buyback
London Stock Exchange Group's stock rose 4.7% to 7,714 pence following reports that activist investor Elliott Management has built a significant stake and is pushing for a new multibillion-pound share repurchase program and improved margins.
BAT Chair Term Extended Ahead of Key Earnings Report
British American Tobacco shares gained 0.6% after the board extended Chair Luc Jobin's tenure to April 2028. Investors await the company's annual results, due Thursday.
Unilever Faces Valuation Test Ahead of Earnings Following Deutsche Bank Downgrade
Unilever shares rose 1.53% to 5,244p despite a Deutsche Bank downgrade to 'hold' on valuation concerns. The consumer goods giant reports Q4 and full-year 2025 results on Feb. 12.
Lloyds Banking Group Announces Fresh Share Buyback Amid Market Focus on Capital Returns
Lloyds Banking Group has initiated a new share repurchase program, acquiring 10 million shares for cancellation, following a recent stock decline. Investors are assessing capital return plans and UK interest rate outlook ahead of the bank's annual report.
NatWest Shares Under Pressure Ahead of Earnings Amid Wealth Deal Scrutiny
NatWest shares fell 2.4% to 605p as investors assess the impact of its £2.7 billion Evelyn Partners acquisition ahead of Friday's annual results.
GSK's RSV Vaccine Advances in Chinese Regulatory Review, Eyes 2027 Decision
GSK's Arexvy RSV vaccine application has been accepted for review by China's drug regulator, with a potential approval decision expected in 2027. The stock edged higher as JPMorgan raised its price target and the company's dividend ex-date approaches.
Barclays Initiates £1 Billion Buyback Amid Profit Growth and U.S. Fee Concerns
Barclays has commenced a £1 billion share repurchase program following a 12% rise in annual pretax profit, while investors monitor regulatory risks to its U.S. card operations.
Indian Indices Climb on Trade Deal Hopes, Domestic Buying Offsets Foreign Outflows
Indian benchmarks advanced Wednesday, with the Nifty50 nearing 26,000, buoyed by optimism over a potential India-US trade agreement and significant net purchases by domestic institutions.
Lumentum Shares Slide in Extended Trading Ahead of Key Investor Conferences
Lumentum Holdings stock declined 2.8% in after-hours trading following a volatile session, as investors await management commentary at upcoming Susquehanna and Morgan Stanley events.
ServiceNow Leads Software Rebound as Analysts Cite AI Overreaction
ServiceNow shares climbed 2.5% to $106.48, leading a broader software recovery after a recent selloff. JPMorgan and Morgan Stanley analysts attributed the decline to sentiment-driven AI fears rather than fundamental weakness.